Zydus Secures CDSCO Panel Go-Ahead For Phase III Trial of Empagliflozin-Metoprolol FDC Parthika Patel22 July 2025 6:19 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Cardiovascular division of the Central Drugs Standard Control Organisation (CDSCO) has...
1-Year Ban for Fake Docs, Mandatory Disposal of Near-Expiry Stock: CDSCO Revises Pharma Export Rules Farhat Nasim21 July 2025 11:51 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has issued a revised guidance document detailing the procedure for the issuance of...
CDSCO Panel Nod To MSD's Sotatercept Label Change, Expands Prescribing Rights to Cardiologists Parthika Patel21 July 2025 10:32 PM ISTNew Delhi: The Subject Expert Committee (SEC) under Central Drugs Standard Control Organisation's (CDSCO) Cardiovascular division has approved MSD...
State Drug Alert: 130 Batches Found Not of Standard Quality in June; No Data Received from Delhi, Gujarat, UP Farhat Nasim20 July 2025 5:36 PM ISTNew Delhi: Reflecting ongoing concerns around drug quality in India's pharmaceutical supply chain, the Central Drugs Standard Control Organisation...
CDSCO Panel Clears AstraZeneca's Datopotamab for Breast Cancer, Seeks Phase IV Trial Parthika Patel20 July 2025 1:03 AM ISTNew Delhi: The Subject Expert Committee (SEC) under the Oncology division of the Central Drugs Standard Control Organisation (CDSCO) has granted...
CDSCO Flags 55 Substandard, 4 Spurious Drugs in June Batch Alert, Full List Inside Farhat Nasim19 July 2025 3:00 PM ISTNew Delhi: In its latest regulatory update for June 2025, the Central Drugs Standard Control Organisation (CDSCO) has flagged a total of 55 drug...
Zydus Asked to Revise Phase III Trial Protocol for Cough Syrup FDC After CDSCO Panel Review Dr. Divya Colin18 July 2025 9:52 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended key revisions to the Phase...
Expert Drug Panel Clears Proposal to Amend Licensing Forms for Advanced Biologics, Xenografts Parthika Patel16 July 2025 4:15 PM ISTNew Delhi: The apex advisory body functioning under the Central Drugs Standard Control Organisation (CDSCO), Drugs Consultative Committee (DCC),...
No Eligible Successor: Centre Clarifies DCGI's Contractual Reappointment Farhat Nasim15 July 2025 9:30 PM ISTNew Delhi: Amid an ongoing legal challenge in the Madurai High Court, the Central government has clarified that its decision to reappoint Dr Rajeev...
Zydus Gets SEC Nod to Begin Phase IV Trial of Dydrogesterone ER for Habitual Miscarriage Parthika Patel15 July 2025 8:21 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Reproductive division of the Central Drugs Standard Control Organisation (CDSCO) has granted...
CDSCO Panel Approves GSK's Proposal to Double Indian Patient Pool in Dostarlimab Trial Parthika Patel15 July 2025 7:34 PM ISTNew Delhi: In a recent regulatory development, the Subject Expert Committee (SEC) under the Oncology division of the Central Drugs Standard Control...
Do Not Issue Licenses Without New Drug Permission from DCGI, Govt Panel Tells States Farhat Nasim14 July 2025 11:28 PM ISTNew Delhi: In a move to reinforce coordination between central and state drug regulatory bodies, the Drugs Consultative Committee (DCC) has called on...
